- Danish stocks
- First North Copenhagen
- Bavarian Nordic
- Chr. Hansen
- DanDrit Biotech
- GN Store Nord
- Novo Nordisk
- Veloxis Pharmaceuticals
- William Demant
- Zealand Pharma
- Norwegian stocks
- Swedish stocks
- A1M Pharma
- Accelerator Nordic
- Clinical Laserthermia
- Eurocine Vaccines
- European Inst. of Science
- IDL Biotech
- Medfield Diagnostics
- Micropos Medical
- Rubicon Life Science
- SPAGO Imaging
- Vivoline Medical
- First North Stockholm
- OMX Stockholm A-F
- OMX Stockholm G-Z
- US stocks
- General discussion
- All posts
“When – oh when – will we see a Distribution Agreement ? ” This must have been the most prominent question on the minds of BioPorto-shareholders this year.
Looking at the debates/discussions/polls here on MI – (The Lesser Evil) it certainly has been the predominant topic (apart from OD and EPO)
One could of course also have asked -” will we ever see a distribution agreement ?” , but with the recent interviews in Medwatch.dk in mind – that questions seems more or less settled.
From a shareholders point of view it is reassuring that it’s now more a question of when – rather than if….
I have looked into the options…
A: Distribution Agreement signed and published end of June
B: Distribution Agreement signed first or second week of July
C: Distribution Agreement signed at the AACC conference 15-19th of July 2012 in LA
D: Distribution Agreement signed during August
E: Distribution Agreement at Kidney Week in late october
lets rule out the latter two – if an agreement was that far off (E) – then the company would have to say so.. (D) is also quite unlikely – basically beacuse most companies have their summervacation in august..
that leaves three options…
A – well time is running out, and we have been unable to intercept any “stealth” info or any unusual activity at Grusbakken – I consider it highly unlikely that something happens this week
B – first/second week July. Could very well be the case given the fact that the Phadia verdict came only a couple of weeks ago
C – AACC july 2012 (third week) – well – its the worlds largest venue for clinical laboratory equipment, and traditionally the meeting point of the whole industry. Exhibitions are nowadays primarily used as marketing tools (rather then sales) – you have the undivided attention of the media, and you have a splendid opportunity to “spread the word…”
I think I’ll settle for C…
I have arranged a small survey/poll – please participate –
- NGAL test Distribution Agreement with Wiener Group Today BioPorto announced that they have entered into a Distribution...
- NGAL will we see an Agreement in Q2 ? Will BioPorto deliver a signed sealed delivered and binding Distribution...
- The first (and so far only) NGAL license agreement. In march 2011, Bioporto signed the first non-exclusive license agreement...
- NGAL BioPorto and Phadia in Medwatch.dk NGAL – For the benefit of our esteemed readers from...
- BioPorto Q1 figures, a positive non-event Today BioPorto released its Q1 figures. Nothing much was expected,...